229 related articles for article (PubMed ID: 30295962)
21. The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma.
Fung SW; Cheung PF; Yip CW; Ng LW; Cheung TT; Chong CC; Lee C; Lai PB; Chan AW; Tsao GS; Wong CH; Chan SL; Lo KW; Cheung ST
Cancer Lett; 2019 Aug; 457():98-109. PubMed ID: 31100412
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
23. Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
Kong X; Peng H; Liu P; Fu X; Wang N; Zhang D
Cancer Sci; 2023 Jun; 114(6):2265-2276. PubMed ID: 36751987
[TBL] [Abstract][Full Text] [Related]
24. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
Modi SJ; Kulkarni VM
Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
[TBL] [Abstract][Full Text] [Related]
25. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins.
Zhang N; Li H; Qin C; Ma D; Zhao Y; Zhu W; Wang L
J Cancer Res Clin Oncol; 2019 Apr; 145(4):895-907. PubMed ID: 30820716
[TBL] [Abstract][Full Text] [Related]
26. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
27. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
29. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
30. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
31. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
Chen C; Song G; Xiang J; Zhang H; Zhao S; Zhan Y
Biochem Biophys Res Commun; 2017 Apr; 486(2):514-520. PubMed ID: 28322787
[TBL] [Abstract][Full Text] [Related]
32. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
[TBL] [Abstract][Full Text] [Related]
33. Lack of hepatic stimulator substance expression promotes hepatocellular carcinoma metastasis partly through ERK-activated epithelial-mesenchymal transition.
Jia XW; Li ZW; Dong LY; Sun GY; Wang X; Gao J; Li YP; Wu Y; An W
Lab Invest; 2018 Jul; 98(7):871-882. PubMed ID: 29497174
[TBL] [Abstract][Full Text] [Related]
34. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
[TBL] [Abstract][Full Text] [Related]
35. Chronic alcohol exposure promotes HCC stemness and metastasis through
Chen D; Yan Y; Wang X; Li S; Liu Y; Yu D; He Y; Deng R; Liu Y; Xu M; Luo J; Gao H; Wang S
Aging (Albany NY); 2021 May; 13(10):14433-14455. PubMed ID: 34019487
[TBL] [Abstract][Full Text] [Related]
36. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):185-187. PubMed ID: 29552781
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition.
Gao Y; Ruan B; Liu W; Wang J; Yang X; Zhang Z; Li X; Duan J; Zhang F; Ding R; Tao K; Dou K
Oncotarget; 2015 Apr; 6(10):7828-37. PubMed ID: 25797261
[TBL] [Abstract][Full Text] [Related]
38. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
[TBL] [Abstract][Full Text] [Related]
39. Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma.
Zhu F; Li X; Chen S; Zeng Q; Zhao Y; Luo F
Med Oncol; 2016 Feb; 33(2):17. PubMed ID: 26781124
[TBL] [Abstract][Full Text] [Related]
40. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
